Loading...
Loading...
ImmunoGen Inc
IMGN dipped 23.12% to $6.45 in the pre-market session. IMGN has received a Refuse to File (RTF) letter from the FDA for its breast cancer treatment.
OmniVision Technologies Inc
OVTI lost 2.85% to $21.50 in the pre-market session. OVTI had reported weaker-than-expected Q1 revenue.
Novell Inc
NOVL fell 2.30% to $5.51 in the pre-market session. NOVL had posted weaker-than-expected FQ3 results.
ARM Holdings Plc
ARMH slipped 0.91% to $15.29 in pre-market trading. ARMH’s earnings are likely to fall by 8.26% this year.
Read more
from Benzinga's Company news.© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: EarningsNewsFDAPre-Market OutlookIntraday UpdateMarketsTrading IdeasBiotechnologyHealth CareInformation TechnologySemiconductorsSystems SoftwareTop Pre-Market NASDAQ Losers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in